Lazard Asset Management LLC Purchases 745,421 Shares of DENTSPLY SIRONA Inc. $XRAY

Lazard Asset Management LLC increased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 8.0% in the 2nd quarter, Holdings Channel reports. The firm owned 10,107,657 shares of the medical instruments supplier’s stock after buying an additional 745,421 shares during the quarter. Lazard Asset Management LLC owned about 0.05% of DENTSPLY SIRONA worth $160,508,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. Public Employees Retirement System of Ohio raised its stake in shares of DENTSPLY SIRONA by 1.4% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock valued at $983,000 after buying an additional 861 shares in the last quarter. Gabelli Funds LLC boosted its position in shares of DENTSPLY SIRONA by 1.0% during the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after acquiring an additional 1,000 shares in the last quarter. AlphaQuest LLC increased its stake in DENTSPLY SIRONA by 2.5% in the second quarter. AlphaQuest LLC now owns 52,817 shares of the medical instruments supplier’s stock valued at $839,000 after acquiring an additional 1,294 shares during the period. Empowered Funds LLC raised its position in DENTSPLY SIRONA by 8.8% in the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after purchasing an additional 1,320 shares in the last quarter. Finally, Parkside Financial Bank & Trust raised its position in DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.50% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

XRAY has been the topic of a number of recent research reports. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. Zacks Research cut DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. UBS Group cut their price objective on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a report on Tuesday, October 28th. Finally, Mizuho set a $13.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, November 7th. Two investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $15.77.

DENTSPLY SIRONA Stock Down 0.3%

NASDAQ XRAY opened at $11.57 on Friday. The stock’s 50 day simple moving average is $11.75 and its 200 day simple moving average is $13.77. DENTSPLY SIRONA Inc. has a one year low of $9.85 and a one year high of $20.59. The firm has a market cap of $2.31 billion, a PE ratio of -2.62, a price-to-earnings-growth ratio of 0.85 and a beta of 1.01. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The business had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.DENTSPLY SIRONA’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.